首页> 外文期刊>Urology >Surgical management, complications, and outcome of radical nephrectomy with inferior vena cava tumor thrombectomy facilitated by vascular bypass.
【24h】

Surgical management, complications, and outcome of radical nephrectomy with inferior vena cava tumor thrombectomy facilitated by vascular bypass.

机译:下腔静脉肿瘤血栓切除术的根治性肾切除术的手术管理,并发症和结局由血管旁路术促进。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVES: To describe the technique, complications, and outcomes of vascular bypass during radical nephrectomy and tumor thrombectomy for patients with renal cell carcinoma and venous tumor thrombus. The indications and results for venovenous bypass (VVB) versus cardiopulmonary bypass (CPB) were reviewed as well. METHODS: We identified 41 patients who had undergone radical nephrectomy and thrombectomy requiring VVB (n = 13) or CPB (n = 28) at our institution from 1970 to 2005 for renal cell carcinoma with venous tumor thrombus. The clinicopathologic variables and complication rates were compared between the VVB and CPB patients. The postoperative cancer-specific survival was estimated using the Kaplan-Meier method and compared using the log-rank test. RESULTS: The patients undergoing VVB experienced significantly shorter median bypass times (P = 0.015), operative times (P 0.001), and anesthesia times (P 0.001) compared with those treated with CPB. In addition, VVB was associated with trends toward decreased median intraoperative blood loss (1200 mL versus 2725 mL, P = 0.336), decreased blood/blood products transfused (median 2300 mL versus 4275 mL, P = 0.256), and decreased length of hospitalization (median 7 days versus 9 days, P = 0.078). The 5-year cancer-specific survival rate was not significantly different for patients undergoing VVB (29.8%) versus those treated with CPB (36.4%; P = 0.989). CONCLUSIONS: VVB was associated with significantly shorter bypass, operative, and anesthesia times, as well as trends toward decreased blood loss and hospital stay. Although the choice of bypass technique must be individualized according to the assessment of the bulk of thrombus to be resected, our results support the continued use of VVB in the management of renal cell carcinoma with extensive venous tumor thrombus, when appropriate.
机译:目的:描述肾癌和静脉肿瘤血栓患者在根治性肾切除术和肿瘤血栓切除术中进行血管旁路术的技术,并发症和结果。还回顾了静脉旁路(VVB)与体外循环(CPB)的适应症和结果。方法:我们确定了从1970年至2005年在我们机构中接受VVB(n = 13)或CPB(n = 28)的41例行根治性肾切除术和血栓切除术的患者,这些患者患有静脉肿瘤血栓的肾细胞癌。比较了VVB和CPB患者的临床病理变量和并发症发生率。使用Kaplan-Meier方法评估术后癌症特异性生存率,并使用对数秩检验进行比较。结果:与CPB相比,接受VVB的患者的中位旁路时间(P = 0.015),手术时间(P <0.001)和麻醉时间(P <0.001)明显缩短。此外,VVB与术中平均失血量减少(1200 mL对2725 mL,P = 0.336),输血/输血量减少(中位数2300 mL对4275 mL,P = 0.256)和住院时间减少的趋势相关。 (中位数7天vs 9天,P = 0.078)。接受VVB治疗的患者(29.8%)与接受CPB治疗的患者(36.4%; P = 0.989)的5年癌症特异性生存率无显着差异。结论:VVB与明显缩短的旁路,手术和麻醉时间,以及失血和住院时间减少的趋势有关。尽管旁路技术的选择必须根据要切除的血栓的数量进行个性化评估,但我们的研究结果支持在适当的情况下继续使用VVB治疗具有广泛静脉肿瘤血栓的肾细胞癌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号